Balancing Stroke and Cardiac Risks: DOACs versus Warfarin in Atrial Fibrillation with Mitral Stenosis
anticoagulation safetymitral stenosisstroke preventionWarfarinDirect Oral Anticoagulantsatrial fibrillation
Highlight
– Direct oral anticoagulants (DOACs) showed a higher 1-year risk of ischemic and composite stroke compared to warfarin in patients with atrial fibrillation and mitral stenosis (AF-MS).
– DOACs were associated with a lower risk of myocardial infarction at 1 year.
– No significant difference was found between DOACs and warfarin regarding bleeding complications or all-cause mortality.
– Rivaroxaban, a specific DOAC, was linked to increased ischemic stroke risk in both short- and long-term follow-up.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.